Berlin - Delayed Quote • EUR Adaptimmune Therapeutics PLC (473A.BE) Follow Add holdings 0.2400 -0.0020 (-0.83%) At close: May 30 at 5:20:06 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure Undo Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 473A.BE 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 473A.BE View More All News Press Releases SEC Filings Adaptimmune Therapeutics PLC (ADAP) Q1 2025 Earnings Call Highlights: Strong Tecelra Launch ... Adaptimmune Reports Q1 Financial Results and Provides Business Update Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025 ADAP 4Q24 Earnings Review: EPS Miss on 1x Restructuring/Impairment Costs; Potential Capital Raise Adds Risk to the Story Adaptimmune Therapeutics PLC (ADAP) (Q4 2024) Earnings Call Highlights: Strategic Growth and ... ADAP: 4Q24 Business Update: Tecelra Launch Progressing + Incremental Cost Savings; Banker-Led Process to Explore Strategic Options Adaptimmune Provides Q4 and Full Year 2024 Business Update From cancer vaccines to COPD treatments, these 10 companies are developing innovative medicines Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025 Adaptimmune Therapeutics plc's (NASDAQ:ADAP) top owners are retail investors with 50% stake, while 25% is held by hedge funds Adaptimmune to Participate in the Guggenheim Securities SMID Cap Biotech Conference February 6, 2025 Related Tickers 9LB.DU Legend Biotech Corp 24.80 -1.59% 9LB.BE Legend Biotech Corp 25.40 0.00% 6A3A.F Autolus Therapeutics plc 1.5200 +4.11% LEGN Legend Biotech Corporation 28.95 -0.07% ALLO Allogene Therapeutics, Inc. 1.1700 -0.85% CRBU Caribou Biosciences, Inc. 1.0600 -8.62%